These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22971818)

  • 1. Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001.
    Poirier JT; Reddy PS; Idamakanti N; Li SS; Stump KL; Burroughs KD; Hallenbeck PL; Rudin CM
    J Gen Virol; 2012 Dec; 93(Pt 12):2606-2613. PubMed ID: 22971818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers.
    Reddy PS; Burroughs KD; Hales LM; Ganesh S; Jones BH; Idamakanti N; Hay C; Li SS; Skele KL; Vasko AJ; Yang J; Watkins DN; Rudin CM; Hallenbeck PL
    J Natl Cancer Inst; 2007 Nov; 99(21):1623-33. PubMed ID: 17971529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus.
    Miles LA; Burga LN; Gardner EE; Bostina M; Poirier JT; Rudin CM
    J Clin Invest; 2017 Aug; 127(8):2957-2967. PubMed ID: 28650343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features.
    Rudin CM; Poirier JT; Senzer NN; Stephenson J; Loesch D; Burroughs KD; Reddy PS; Hann CL; Hallenbeck PL
    Clin Cancer Res; 2011 Feb; 17(4):888-95. PubMed ID: 21304001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Structure-Guided Genetic Modification Strategy: Developing Seneca Valley Virus Therapy against Nonsensitive Nonsmall Cell Lung Carcinoma.
    Zhao Z; Cao L; Sun Z; Liu W; Li X; Fang K; Shang X; Hu J; Chen H; Lou Z; Qian P
    J Virol; 2023 May; 97(5):e0045923. PubMed ID: 37097154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma.
    Liu Z; Zhao X; Mao H; Baxter PA; Huang Y; Yu L; Wadhwa L; Su JM; Adesina A; Perlaky L; Hurwitz M; Idamakanti N; Police SR; Hallenbeck PL; Hurwitz RL; Lau CC; Chintagumpala M; Blaney SM; Li XN
    Neuro Oncol; 2013 Sep; 15(9):1173-85. PubMed ID: 23658322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer.
    Poirier JT; Dobromilskaya I; Moriarty WF; Peacock CD; Hann CL; Rudin CM
    J Natl Cancer Inst; 2013 Jul; 105(14):1059-65. PubMed ID: 23739064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of duck hepatitis A virus 3 from a stable full-length infectious cDNA clone.
    Pan M; Yang X; Du J; Zhou L; Ge X; Guo X; Liu J; Zhang D; Yang H
    Virus Res; 2011 Sep; 160(1-2):439-43. PubMed ID: 21801768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of a full-length cDNA infectious clone of emerging porcine Senecavirus A.
    Chen Z; Yuan F; Li Y; Shang P; Schroeder R; Lechtenberg K; Henningson J; Hause B; Bai J; Rowland RRR; Clavijo A; Fang Y
    Virology; 2016 Oct; 497():111-124. PubMed ID: 27459668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of infectious transcripts from full-length and GFP-tagged cDNA clones of Pepper mottle virus and stable systemic expression of GFP in tobacco and pepper.
    Lee MY; Song YS; Ryu KH
    Virus Res; 2011 Feb; 155(2):487-94. PubMed ID: 21167886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious simian varicella virus expressing the green fluorescent protein.
    Mahalingam R; Wellish M; White T; Soike K; Cohrs R; Kleinschmidt-DeMasters BK; Gilden DH
    J Neurovirol; 1998 Aug; 4(4):438-44. PubMed ID: 9718136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic Seneca Valley Virus: past perspectives and future directions.
    Burke MJ
    Oncolytic Virother; 2016; 5():81-9. PubMed ID: 27660749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a recombinant Newcastle disease virus expressing the green fluorescent protein.
    Engel-Herbert I; Werner O; Teifke JP; Mebatsion T; Mettenleiter TC; Römer-Oberdörfer A
    J Virol Methods; 2003 Mar; 108(1):19-28. PubMed ID: 12565150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of Seneca Valley Virus-001: an oncolytic picornavirus representing a new genus.
    Venkataraman S; Reddy SP; Loo J; Idamakanti N; Hallenbeck PL; Reddy VS
    Structure; 2008 Oct; 16(10):1555-61. PubMed ID: 18940610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors.
    Wei D; Sun N; Nan G; Wang Y; Liu HQ; Peeters B; Chen ZN; Bian H
    Hum Gene Ther; 2012 Jul; 23(7):700-10. PubMed ID: 22372930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for anthrax toxin receptor 1 recognition by Seneca Valley Virus.
    Jayawardena N; Burga LN; Easingwood RA; Takizawa Y; Wolf M; Bostina M
    Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10934-E10940. PubMed ID: 30381454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Assessment of the Health Risk for Livestock When Animal Viruses Are Applied in Human Oncolytic Therapy: A Case Study for Seneca Valley Virus.
    Schijven J; Brizee S; Teunis P; de Vos C; Eblé P; Rutjes S
    Risk Anal; 2019 May; 39(5):982-991. PubMed ID: 30395685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer.
    Chai Z; Zhang P; Fu F; Zhang X; Liu Y; Hu L; Li X
    Virol J; 2014 May; 11():84. PubMed ID: 24885546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy.
    Kanai R; Eguchi K; Takahashi M; Goldman S; Okano H; Kawase T; Yazaki T
    J Gene Med; 2006 Nov; 8(11):1329-40. PubMed ID: 16955534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue of NanoLuc luciferase-expressing Senecavirus A with oncolytic activity.
    Liu F; Wang Q; Huang Y; Wang N; Shan H
    Virus Res; 2021 Jan; 292():198232. PubMed ID: 33207264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.